International Mammalian Genome Society

logo18th International Mouse Genome Conference

17-22 October 2004, Seattle, USA


Welcome to the 18th International Mouse Genome Conference

Sheraton Hotel, Seattle, October 18-21, 2004

With a mouse genome draft sequence available and a final genome sequence about to be in hand, the foundation is set for progress in understanding the roles of gene function in development and in disease. Advances in the manipulation of the mouse genome has led to the emergence of novel ways to explore basic biology and the development of relevant models of human disease. Highlighted themes for the conference include the genetics of aging and infectious disease and advances in gene therapy using RNAi. Epigenetics and comparative genomics are also spotlighted in the program. Richard Palmiter, a pioneer in the development of transgenic mouse technology and its application to the study of the role of genes in development and disease, will give the Verne Chapman Memorial lecture.

Many people contributed to the organization of this meeting and we are grateful to the members of the Secretariat of the International Mammalian Genome Society for their contributions in planning the scientific presentations. Darla Miller, as usual, has been invaluable in bringing this meeting to fruition. And the excellent efforts of Katy Armstrong, Emily Walton and Hayley Burton along with the rest of the staff at In Conference (Edinburgh) made our job in Seattle much easier and efficient.  Sandya Narayanswami was especially valuable in guiding our local and foundation fund raising efforts.  We would also like to give special thanks to Kris Carroll for creating the IMGC 2004 logo.

Sponsorship for this meeting comes from a variety of sources, but primarily from the US National Institutes of Health, the US Department of Energy, and Mouse Newsletter Ltd. These sources fund a number of student scholarships, as well as the speaker travel.  In addition to these sources, we have received contributions from a variety of pharmaceutical and publishing companies who are gratefully acknowledged. This year we were particularly fortunate to receive funding from the Ellison Medical Foundation, which is supporting two sessions, the Genetics of Infectious Disease and Genome Instability and Aging. These sessions correspond to the Ellison Medical Foundation’s focus areas and this support is a clear acknowledgement of the important contributions of the mouse community to the understanding and treatment of human disease. 

Seattle is home to a dynamic scientific community with a very strong interest in mouse genetics, and that combined with a spectacular setting between mountains and sea, sets the stage for a rewarding meeting. We welcome you to Seattle and the 18th International Mouse Genome Conference.

Christine Disteche1 and David Adler1,2 

1Department of Pathology, University of Washington, 2Zymogenetics, Seattle WA

[an error occurred while processing this directive]